Efficacy and tolerability of solifenacin and tamsulosin in patients with benign prostatic hyperplasia and overactive bladder

Trial Profile

Efficacy and tolerability of solifenacin and tamsulosin in patients with benign prostatic hyperplasia and overactive bladder

Completed
Phase of Trial: Phase II

Latest Information Update: 30 Aug 2013

At a glance

  • Drugs Solifenacin; Tamsulosin
  • Indications Benign prostatic hyperplasia; Overactive bladder
  • Focus Adverse reactions; Therapeutic Use
  • Most Recent Events

    • 30 Aug 2013 Results presented at the 43rd Annual Meeting of the International Continence Society.
    • 30 Aug 2013 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top